Therapeutic apheresis in kidney diseases: an updated review
Besides conventional medical therapies, therapeutic apheresis has become an important adjunctive or alternative therapeutic option to immunosuppressive agents for primary or secondary kidney diseases and kidney transplantation. The available therapeutic apheresis techniques used in kidney diseases,...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2022.2073892 |
| _version_ | 1818252780529254400 |
|---|---|
| author | Yi-Yuan Chen Xin Sun Wei Huang Fang-Fang He Chun Zhang |
| author_facet | Yi-Yuan Chen Xin Sun Wei Huang Fang-Fang He Chun Zhang |
| author_sort | Yi-Yuan Chen |
| collection | DOAJ |
| description | Besides conventional medical therapies, therapeutic apheresis has become an important adjunctive or alternative therapeutic option to immunosuppressive agents for primary or secondary kidney diseases and kidney transplantation. The available therapeutic apheresis techniques used in kidney diseases, including plasma exchange, double-filtration plasmapheresis, immunoadsorption, and low-density lipoprotein apheresis. Plasma exchange is still the leading extracorporeal therapy. Recently, growing evidence supports the potential benefits of double-filtration plasmapheresis and immunoadsorption for more specific and effective clearance of pathogenic antibodies with fewer side effects. However, more randomized controlled trials are still needed. Low-density lipoprotein apheresis is also an important supplementary therapy used in patients with recurrent focal segmental glomerulosclerosis. This review collects the latest evidence from recent studies, focuses on the specific advantages and disadvantages of these techniques, and compares the discrepancy among them to determine the optimal therapeutic regimens for certain kidney diseases. |
| first_indexed | 2024-12-12T16:29:37Z |
| format | Article |
| id | doaj.art-83348e1f0884456fa19dfd01c45b381e |
| institution | Directory Open Access Journal |
| issn | 0886-022X 1525-6049 |
| language | English |
| last_indexed | 2024-12-12T16:29:37Z |
| publishDate | 2022-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Renal Failure |
| spelling | doaj.art-83348e1f0884456fa19dfd01c45b381e2022-12-22T00:18:49ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492022-12-0144184285710.1080/0886022X.2022.2073892Therapeutic apheresis in kidney diseases: an updated reviewYi-Yuan Chen0Xin Sun1Wei Huang2Fang-Fang He3Chun Zhang4Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaBesides conventional medical therapies, therapeutic apheresis has become an important adjunctive or alternative therapeutic option to immunosuppressive agents for primary or secondary kidney diseases and kidney transplantation. The available therapeutic apheresis techniques used in kidney diseases, including plasma exchange, double-filtration plasmapheresis, immunoadsorption, and low-density lipoprotein apheresis. Plasma exchange is still the leading extracorporeal therapy. Recently, growing evidence supports the potential benefits of double-filtration plasmapheresis and immunoadsorption for more specific and effective clearance of pathogenic antibodies with fewer side effects. However, more randomized controlled trials are still needed. Low-density lipoprotein apheresis is also an important supplementary therapy used in patients with recurrent focal segmental glomerulosclerosis. This review collects the latest evidence from recent studies, focuses on the specific advantages and disadvantages of these techniques, and compares the discrepancy among them to determine the optimal therapeutic regimens for certain kidney diseases.https://www.tandfonline.com/doi/10.1080/0886022X.2022.2073892Therapeutic apheresisplasma exchangedouble-filtration plasmapheresisimmunoadsorptionkidney transplantation |
| spellingShingle | Yi-Yuan Chen Xin Sun Wei Huang Fang-Fang He Chun Zhang Therapeutic apheresis in kidney diseases: an updated review Renal Failure Therapeutic apheresis plasma exchange double-filtration plasmapheresis immunoadsorption kidney transplantation |
| title | Therapeutic apheresis in kidney diseases: an updated review |
| title_full | Therapeutic apheresis in kidney diseases: an updated review |
| title_fullStr | Therapeutic apheresis in kidney diseases: an updated review |
| title_full_unstemmed | Therapeutic apheresis in kidney diseases: an updated review |
| title_short | Therapeutic apheresis in kidney diseases: an updated review |
| title_sort | therapeutic apheresis in kidney diseases an updated review |
| topic | Therapeutic apheresis plasma exchange double-filtration plasmapheresis immunoadsorption kidney transplantation |
| url | https://www.tandfonline.com/doi/10.1080/0886022X.2022.2073892 |
| work_keys_str_mv | AT yiyuanchen therapeuticapheresisinkidneydiseasesanupdatedreview AT xinsun therapeuticapheresisinkidneydiseasesanupdatedreview AT weihuang therapeuticapheresisinkidneydiseasesanupdatedreview AT fangfanghe therapeuticapheresisinkidneydiseasesanupdatedreview AT chunzhang therapeuticapheresisinkidneydiseasesanupdatedreview |